Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ODE (office of device evaluation) deputy steps up to top role

This article was originally published in Clinica

Executive Summary

Daniel Schultz, deputy director for clinical and review policy at the US FDA's office of device evaluation (ODE), has moved up to become office director. He replaces Bernard Statland, who left this week to return to law school. "Dan brings to the job a wealth of clinical and administrative experience that should prove invaluable in overseeing the evaluation of new medical devices," David Feigal, director of the Center for Devices and Radiological Health said in announcing the appointment.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts